ResoTher Pharma is pleased to announce the addition of Dr Anthony Mathur to its Scientific Advisory Board. Dr Mathur is Professor and Clinical Director for Interventional Cardiology at Barts Health and a Director at the Centre for Cardiovascular Medicine and Device Innovation at Barts and the London School of Medicine, where he leads the Cardiovascular Devices Hub. His research focuses on examining the role of biologics  in the treatment of cardiovascular disease. Dr Mathur is Chair of the ESC Task Force on stem cells in cardiovascular disease and  leads the Compassionate Stem Cell Treatment Unit for patients with cardiac disease at Barts Heart Centre.

CEO Lone Veng states “We are thrilled to have yet another high-caliber clinical expert such as Dr Mathur join our SAB and feel confident that he will make a great contribution towards the successful clinical development of RTP-026”.